DLK1 and hepatocellular carcinoma: An analysis comparing results of the transcriptome profiling of hepatic cell lines and tumor cells in HB and HCC showed significant differences in the level of DLK1 gene expression in HepG2 cells [102,103,104], which may be necessary for driving chemoresistance and potentiating malignancy in cancers.